Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells

Endocrinology

Volumn 141, Issue 7, 2000, Pages 2401-2409

  Martin, J L ^a   Pattison, S L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CALCITRIOL; DNA; IMMUNOGLOBULIN G; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING;

EID: 0034456403     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.7.7534     Document Type: Article

References (46)

1. The IGF axis in the prostate
2. Regulation of prostatic growth and function by peptide growth factors
3. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia
4. The effect of the insulin-like growth factor system human prostate epithelial cells of immortalization and transformation by Simian virus-40 T antigen
5. Insulin-like growth factors and their binding proteins: Biological actions
6. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate
7. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells - Isolation, characterization and its biological action
8. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3) differential effect on PC-3 and normal prostate cell growth
9. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone-derived In-IGFBP
10. Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts
11. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells
12. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
13. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1 - Evidence for an IGF-II autocrine growth loop
14. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture
15. Regulation of insulin-like growth factor (IGF) II and IGF binding protein-3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)(2)D-3 and its analog EB1089
16. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
17. Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins
18. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
19. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1α,25dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate
20. Insulin-like growth factor binding protein from human plasma. Purification and characterization
21. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
22. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
23. Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from fibroblasts by different mechanisms
24. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-6 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic AMP, and differential effects of estradiol
25. 3 in the androgen-dependent LNCaP cells
26. 3 and 9-cis retinoic acid in LNCaP human prostate cancer cells
27. Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation
28. Transforming growth factorbeta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
29. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells
30. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
31. Testosterone increases insulin-like growth factor-1 and insulin-like growth factor-binding protein
32. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line
33. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNCaP prostatic adenocarcinoma cells
34. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid
35. Insulin-like growth factor binding protein-3: Organisation of the human chromosomal gene and demonstration of promoter activity
36. 3 actions in LNCaP human prostate cancer cells are androgen-dependent
37. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
38. Regulation of proliferation and production of prostate specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone
39. 3
40. Release of fibroblast IGFBPs by TGF-β and IGF-I occurs through distinct mechanisms
41. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
42. Recombinant human insulin-like growth factor (IGFf) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism - Role of serine proteases
43. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
44. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: Evidence for processing of cell-bound IGFBP-3
45. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
46. Insulin-like growth factor-1 - Action and receptor characterization in human prostate cancer cell lines